V.K.V. American Hospital, Istanbul Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2006
NCT00750451
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Alper Tunga Dogan | V.K.V. American Hospital, Istanbul

Active Ingredients

Drugs in Phase 3 Trials (1)

sodium chloride (2 trials)

Drugs in Other Trials (3)

enoxaparin (lovenox) (1 trial)

progesterone (progestasert) (1 trial)

triptorelin (Trelstar) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Infertility (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 4